Sickle Cell Disease Core Concepts for the Emergency

  • Slides: 18
Download presentation
Sickle Cell Disease: Core Concepts for the Emergency Physician and Nurse Epidemiology, Genetics, Pathophysiology

Sickle Cell Disease: Core Concepts for the Emergency Physician and Nurse Epidemiology, Genetics, Pathophysiology Paula Tanabe, Ph. D, RN, FAEN, FAAN Associate Professor Duke University, Schools of Nursing and Medicine

Objectives • Identify the genotype associated with the most severe form of sickle cell

Objectives • Identify the genotype associated with the most severe form of sickle cell disease (SCD) • Identify the median lifespan for individuals with SCD

Pretest- Question 1 Which genotype is associated with the most severe symptoms? a. SS

Pretest- Question 1 Which genotype is associated with the most severe symptoms? a. SS b. SC c. SB 0 d. SB+

Pretest- Question 2 What is the median lifespan for most individuals with SCD? a.

Pretest- Question 2 What is the median lifespan for most individuals with SCD? a. b. c. d. 20’s 30’s 40’s 50’s

Epidemiology of SCD • SCD is a genetic disease affecting 70, 000 – 100,

Epidemiology of SCD • SCD is a genetic disease affecting 70, 000 – 100, 000 Americans, primarily of African descent 1 – Most common genetic disease among blacks – SCD occurs in 1 of every 500 black births • 1: 1, 100 Hispanics (eastern states) • 1: 32, 000 Hispanics (western states) • SCD occurs in many other ethnic groups, including Northern Europeans and those that live in the Middle Eastern Countries • 1: 12 African-Americans are carriers (trait) for the disorder

SCD Common Genotypes Genotype Approximate % of US Patients • Sickle cell anemia (SS,

SCD Common Genotypes Genotype Approximate % of US Patients • Sickle cell anemia (SS, most 65 % severe form) • Sickle/Hb C disease (SC, lesser 25 % severity, but can still have pain episodes, and life-threatening complications) • Sickle/Beta plus thalassemia 8% + (Sβ thalassemia, similar to SC) • Sickle/Beta zero thalassemia 2% (Sβ° thalassemia, similar to SS)

Comparison of Life Expectancy US Population vs. Sickle Cell Disease

Comparison of Life Expectancy US Population vs. Sickle Cell Disease

Changes in Life Expectancy • • National Center for Health Statistics 3 Compared 1999

Changes in Life Expectancy • • National Center for Health Statistics 3 Compared 1999 -2007 with 1979 -1998 Largest declines in ages 0 -4 Smaller but significant declines up to age 19 – Due to prophylactic treatment with penicillin and vaccinations – Transcranial doppler screening identifies children at risk of stroke; placed on chronic transfusion therapy to prevent stroke • No differences in the 20 -24 age group • Increase in death rate ages: 45 -54, 55 -65, and 65 -75

What is the pathophysiology?

What is the pathophysiology?

Normal Vs. Sickle Red Cells Normal Sickle • Biconcave disc-shaped • Deformable • Life

Normal Vs. Sickle Red Cells Normal Sickle • Biconcave disc-shaped • Deformable • Life span of 120 days • • Sickle-shaped Rigid Life span of 20 days or less Sticky surface, abnormal properties

Prolonged Sickling of RBC’s • After recurrent episodes of sickling – membrane damage occurs

Prolonged Sickling of RBC’s • After recurrent episodes of sickling – membrane damage occurs – cells not capable of resuming biconcave shape upon reoxygenation • Deformed sickle cells adhere to endothelium & macrophages – induces hemolytic process

Hemolysis and Vaso-occlusion Hemolysis • Anemia in SCD is caused by red cell destruction,

Hemolysis and Vaso-occlusion Hemolysis • Anemia in SCD is caused by red cell destruction, or hemolysis Vaso-occlusion: • Complex process initiated by rigid and abnormally shaped sickled RBC’s • Degree of anemia varies widely between patients • Abnormal adhesion occurs to the endothelium • Red cell production by the bone marrow increases dramatically, but is unable to keep pace with the destruction • Activation of WBC’s, RBC’s & the endothelial surface which enhances the VOC process • Results in tissue damage, hypoxia, necrosis, & organ dysfunction

Acute and Chronic Manifestations Acute Manifestations Chronic Manifestations • • • • Bacterial sepsis

Acute and Chronic Manifestations Acute Manifestations Chronic Manifestations • • • • Bacterial sepsis or meningitis* Recurrent vaso-occlusive pain (dactylitis, musculo-skeletal or abdominal pain) Splenic sequestration* Aplastic crisis* Acute chest syndrome* Stroke* Priapism Hematuria, including papillary necrosis *Potential cause of mortality • • • Anemia Jaundice Splenomegaly Functional asplenia Cardiomegaly and functional murmurs Hyposthenuria and enuresis Proteinemia Cholelithiasis Delayed growth and sexual maturation Restrictive lung disease* Pulmonary hypertension* Avascular necrosis Proliferative retinopathy Leg ulcers Transfusional hemosiderosis*

Clinical Scenario • Cut and paste this link into your browser to view this

Clinical Scenario • Cut and paste this link into your browser to view this short video • https: //www. youtube. com/watch? v=Uu 5 VTET lb. ZM&feature=youtu. be

Posttest- Question 1 Which genotype is associated with the most severe symptoms? a. SS

Posttest- Question 1 Which genotype is associated with the most severe symptoms? a. SS b. SC c. SB 0 d. SB+

Posttest- Question 2 What is the median lifespan for most individuals with SCD? a.

Posttest- Question 2 What is the median lifespan for most individuals with SCD? a. b. c. d. 20’s 30’s 40’s 50’s

Posttest Answers & Rationale • Question 1 – Answer : a) SS – Rationale:

Posttest Answers & Rationale • Question 1 – Answer : a) SS – Rationale: Patients with SS have the most severe form of the disease which is associated with more complications. However, all patients can experience pain and multiple other complications. • Question 2 – Answer: c) 40’s – Rationale: The median lifespan continues to be 48 for females and 42 for males.

References 1. Hassell KL. Population estimates of sickle cell disease in the U. S.

References 1. Hassell KL. Population estimates of sickle cell disease in the U. S. Am J Prev Med. 2010; 38(4 S): S 512 -S 521. 2. Platt et al. Mortality in sickle cell disease, life expectancy and risk factors for early death. NEJM 1994. 330: 1639 -44. 3. Hamideh, D. Trends in Mortality Among Patients with SCD in the United States. Is there any change in the past 10 years? 2012. 6 th Annual Sickle Cell Disease Research and Educational Symposium & Annual National SCD Scientific Meeting 4. http: //wonder. cdc. gov/controller/datarequest/D 79